Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Four Corners Property Trust heads into its October 28 earnings date with the stock down 15% over the past month and the Street quietly cutting price targets even as ratings stay unchanged.
The most telling move came from JP Morgan this week. Analyst Anthony Paolone kept his Neutral rating but slashed his price target from $29 to $26, a 10% cut filed the same day the stock closed at $21.30. Evercore ISI followed a similar path two weeks ago, trimming its In-Line target from $28 to $26. Barclays bucked the trend in early September, lifting its Equal-Weight target to $30, but that figure now looks optimistic given where the stock has traded since. The consensus mean sits at $27.78, implying roughly 30% upside from current levels, though the gap between price and target has widened because the stock fell faster than targets moved. The Street is broadly neutral: no firm has upgraded, and the direction of travel on targets is clearly lower. The bear case is straightforward: rising interest rates compress REIT valuations and make the dividend yield less competitive, while tenant concentration adds idiosyncratic risk if any key lessee comes under financial stress.
Shorts are not piling in, and the lending market reflects almost no conviction on the bear side. Short interest is 4.3% of free float, a level that has barely moved over the past month, down fractionally on the week. Borrowing costs are negligible at 0.47%. Availability is exceptionally wide, with over 5,300% of current short interest available to borrow, meaning there are more than 53 shares available for every one already lent out. That reading is well above the 52-week trough of 1,138%. Nothing in the lending market suggests short sellers are building a position with any urgency. Options positioning has actually loosened relative to its own recent history: the put/call ratio is 2.01, which sounds elevated in isolation, but the 20-day average is 6.75, making this week's reading nearly 1.5 standard deviations below the norm. Defensive hedging pressure has eased sharply compared to where it was through September.
The valuation compression tells the more uncomfortable story. Price-to-book has dropped 0.24 points over the past 30 days to 1.42x. The PE ratio has compressed by more than 2 points over the same period to 19.6x. EV/EBITDA at 13.1x has held relatively steady. The dividend yield factor scores at the 94th percentile of FCPT's universe, meaning the income proposition remains intact at the current price, but EPS momentum ranks in the bottom 11% on a 90-day basis and the 8th percentile on a 30-day basis, pointing to downward estimate drift into the print. The ORTEX short score of 40 is in the 39th percentile and has drifted lower through the past two weeks, easing from 42.4 on September 30.
The institutional register offers some support. BlackRock holds 18.2% of shares and added 118,000 shares in the period ending September 30. FMR (Fidelity) holds 6.4% and added 875,000 shares in the same period. State Street added 195,000 shares. FMR's 13G filing from August shows its stake fell from 7.9% to 6.5% as at that date, a reduction worth tracking. Recent insider activity was limited to small share accumulations on September 15 across several directors and the CEO, all via transaction code "J" with no price data attached, most likely dividend reinvestment or plan-based allocations rather than open-market purchases.
Peers held up better on the week. GLPI fell just 0.5%, CUBE was down 0.3%, and EXR was roughly flat. EPR matched FCPT's weekly decline at 3.4%, suggesting some sector-wide pressure but with FCPT at the softer end of the group. The October 28 earnings date is now 21 days out. With target cuts arriving just before the quarter closes, the question for the print is whether estimate revisions have been deep enough, or whether the Street's pencils have more work to do.
See the live data behind this article on ORTEX.
Open FCPT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
